Endava PLC has a consensus price target of $45.22, established from looking at the 73 latest analyst ratings. The last 3 analyst ratings were released from Guggenheim, JP Morgan, and TD Cowen on May 24, 2024. With an average price target of $46 between Guggenheim, JP Morgan, and TD Cowen, there's an implied 53.33% upside for Endava PLC from these 3 analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/24/2024 | Buy Now | 83.33% | Guggenheim | Jonathan Lee | $60 → $55 | Maintains | Buy | Get Alert |
05/24/2024 | Buy Now | 36.67% | JP Morgan | Puneet Jain | $43 → $41 | Maintains | Overweight | Get Alert |
05/24/2024 | Buy Now | 40% | TD Cowen | Bryan Bergin | $46 → $42 | Maintains | Buy | Get Alert |
05/24/2024 | Buy Now | 10.33% | Redburn Atlantic | Harry Read | → $33.1 | Initiates | → Neutral | Get Alert |
05/24/2024 | Buy Now | 40% | Needham | Mayank Tandon | $50 → $42 | Maintains | Buy | Get Alert |
05/23/2024 | Buy Now | 66.67% | Wedbush | Moshe Katri | $65 → $50 | Maintains | Outperform | Get Alert |
05/02/2024 | Buy Now | 43.33% | JP Morgan | Tien-Tsin Huang | $49 → $43 | Maintains | Overweight | Get Alert |
05/01/2024 | Buy Now | 50% | HSBC | Phani Kanumuri | → $45 | Upgrade | Hold → Buy | Get Alert |
04/22/2024 | Buy Now | 33.33% | Morgan Stanley | James Faucette | → $40 | Maintains | Equal-Weight | Get Alert |
04/22/2024 | Buy Now | 10% | Citigroup | Ashwin Shirvaikar | $40 → $33 | Maintains | Neutral | Get Alert |
03/19/2024 | Buy Now | 63.33% | JP Morgan | Puneet Jain | → $49 | Upgrade | Neutral → Overweight | Get Alert |
03/19/2024 | Buy Now | 100% | Guggenheim | Jonathan Lee | → $60 | Initiates | → Buy | Get Alert |
03/12/2024 | Buy Now | 120% | Susquehanna | James Friedman | $83 → $66 | Maintains | Positive | Get Alert |
03/12/2024 | Buy Now | 66.67% | Needham | Mayank Tandon | → $50 | Reiterates | Buy → Buy | Get Alert |
03/01/2024 | Buy Now | 33.33% | Citigroup | Ashwin Shirvaikar | $90 → $40 | Downgrade | Buy → Neutral | Get Alert |
03/01/2024 | Buy Now | 73.33% | TD Cowen | Bryan Bergin | $85 → $52 | Maintains | Outperform | Get Alert |
03/01/2024 | Buy Now | 63.33% | JP Morgan | Puneet Jain | $79 → $49 | Maintains | Neutral | Get Alert |
03/01/2024 | Buy Now | 66.67% | Needham | Mayank Tandon | $70 → $50 | Maintains | Buy | Get Alert |
02/14/2024 | Buy Now | 163.33% | JP Morgan | Puneet Jain | $77 → $79 | Maintains | Neutral | Get Alert |
01/24/2024 | Buy Now | 166.67% | Morgan Stanley | James Faucette | $68 → $80 | Downgrade | Overweight → Equal-Weight | Get Alert |
01/17/2024 | Buy Now | 200% | Citigroup | Ashwin Shirvaikar | $70 → $90 | Maintains | Buy | Get Alert |
01/08/2024 | Buy Now | 166.67% | HSBC | Phani Kanumuri | $68 → $80 | Downgrade | Buy → Hold | Get Alert |
12/08/2023 | Buy Now | 156.67% | JP Morgan | Puneet Jain | → $77 | Initiates | → Neutral | Get Alert |
11/16/2023 | Buy Now | 133.33% | Needham | Mayank Tandon | $65 → $70 | Maintains | Buy | Get Alert |
10/02/2023 | Buy Now | 176.67% | Susquehanna | James Friedman | $100 → $83 | Maintains | Positive | Get Alert |
09/20/2023 | Buy Now | 133.33% | TD Cowen | Bryan Bergin | $78 → $70 | Maintains | Outperform | Get Alert |
09/20/2023 | Buy Now | 126.67% | Morgan Stanley | James Faucette | $72 → $68 | Maintains | Overweight | Get Alert |
09/20/2023 | Buy Now | 116.67% | Needham | Mayank Tandon | $68 → $65 | Maintains | Buy | Get Alert |
09/14/2023 | Buy Now | 140% | Morgan Stanley | James Faucette | $70 → $72 | Maintains | Overweight | Get Alert |
07/24/2023 | Buy Now | 133.33% | Morgan Stanley | James Faucette | $70 → $70 | Reiterates | Overweight → Overweight | Get Alert |
07/17/2023 | Buy Now | 133.33% | Morgan Stanley | James Faucette | $70 → $70 | Reiterates | Overweight → Overweight | Get Alert |
07/17/2023 | Buy Now | 146.67% | HSBC | Phani Kanumuri | → $74 | Initiates | → Buy | Get Alert |
06/26/2023 | Buy Now | 133.33% | Morgan Stanley | James Faucette | $70 → $70 | Reiterates | Overweight → Overweight | Get Alert |
06/20/2023 | Buy Now | 133.33% | Morgan Stanley | James Faucette | → $70 | Reiterates | Overweight → Overweight | Get Alert |
06/12/2023 | Buy Now | 133.33% | Morgan Stanley | James Faucette | → $70 | Reiterates | → Overweight | Get Alert |
06/12/2023 | Buy Now | 233.33% | Susquehanna | James Friedman | $104 → $100 | Maintains | Positive | Get Alert |
06/12/2023 | Buy Now | 120% | TD Cowen | Bryan Bergin | $76 → $66 | Maintains | Outperform | Get Alert |
06/05/2023 | Buy Now | 126.67% | Needham | Mayank Tandon | → $68 | Reiterates | Buy → Buy | Get Alert |
05/24/2023 | Buy Now | 76.67% | Deutsche Bank | Bryan Keane | $78 → $53 | Maintains | Hold | Get Alert |
05/24/2023 | Buy Now | 133.33% | Morgan Stanley | James Faucette | $95 → $70 | Maintains | Overweight | Get Alert |
05/24/2023 | Buy Now | 246.67% | Susquehanna | James Friedman | $112 → $104 | Maintains | Positive | Get Alert |
05/24/2023 | Buy Now | 126.67% | Needham | Mayank Tandon | $90 → $68 | Maintains | Buy | Get Alert |
05/19/2023 | Buy Now | 216.67% | Morgan Stanley | James Faucette | $105 → $95 | Maintains | Overweight | Get Alert |
05/01/2023 | Buy Now | 183.33% | Citigroup | Ashwin Shirvaikar | $95 → $85 | Maintains | Buy | Get Alert |
04/20/2023 | Buy Now | 273.33% | Susquehanna | James Friedman | $120 → $112 | Maintains | Positive | Get Alert |
02/16/2023 | Buy Now | 216.67% | Citigroup | Ashwin Shirvaikar | $105 → $95 | Maintains | Buy | Get Alert |
02/15/2023 | Buy Now | 250% | Morgan Stanley | James Faucette | $110 → $105 | Maintains | Overweight | Get Alert |
02/15/2023 | Buy Now | 200% | Cowen & Co. | Bryan Bergin | $95 → $90 | Maintains | Outperform | Get Alert |
02/15/2023 | Buy Now | 200% | Needham | Mayank Tandon | $100 → $90 | Maintains | Buy | Get Alert |
01/27/2023 | Buy Now | 266.67% | Morgan Stanley | James Faucette | $95 → $110 | Maintains | Overweight | Get Alert |
11/21/2022 | Buy Now | 250% | Citigroup | Ashwin Shirvaikar | $110 → $105 | Maintains | Buy | Get Alert |
11/16/2022 | Buy Now | 300% | Susquehanna | James Friedman | $110 → $120 | Maintains | Positive | Get Alert |
11/16/2022 | Buy Now | 233.33% | Needham | Mayank Tandon | $112 → $100 | Maintains | Buy | Get Alert |
09/28/2022 | Buy Now | 160% | Deutsche Bank | Bryan Keane | $94 → $78 | Maintains | Hold | Get Alert |
09/28/2022 | Buy Now | 200% | Wedbush | Moshe Katri | $120 → $90 | Maintains | Outperform | Get Alert |
09/28/2022 | Buy Now | 266.67% | Susquehanna | James Friedman | $150 → $110 | Maintains | Positive | Get Alert |
09/28/2022 | Buy Now | 216.67% | Morgan Stanley | James Faucette | $130 → $95 | Maintains | Overweight | Get Alert |
09/28/2022 | Buy Now | 266.67% | Citigroup | Ashwin Shirvaikar | $145 → $110 | Maintains | Buy | Get Alert |
09/27/2022 | Buy Now | 273.33% | Needham | Mayank Tandon | $135 → $112 | Maintains | Buy | Get Alert |
09/13/2022 | Buy Now | — | Keybanc | Thomas Blakey | — | Initiates | → Sector Weight | Get Alert |
05/16/2022 | Buy Now | 300% | Wedbush | Moshe Katri | $200 → $120 | Maintains | Outperform | Get Alert |
05/13/2022 | Buy Now | 213.33% | Deutsche Bank | Bryan Keane | $154 → $94 | Maintains | Hold | Get Alert |
05/13/2022 | Buy Now | 400% | Susquehanna | James Friedman | $200 → $150 | Maintains | Positive | Get Alert |
05/13/2022 | Buy Now | 333.33% | Morgan Stanley | James Faucette | $190 → $130 | Maintains | Overweight | Get Alert |
05/13/2022 | Buy Now | 350% | Needham | Mayank Tandon | $195 → $135 | Maintains | Buy | Get Alert |
02/17/2022 | Buy Now | 533.33% | Morgan Stanley | James Faucette | $185 → $190 | Maintains | Overweight | Get Alert |
02/17/2022 | Buy Now | 500% | Citigroup | Ashwin Shirvaikar | $195 → $180 | Maintains | Buy | Get Alert |
01/10/2022 | Buy Now | 516.67% | Morgan Stanley | James Faucette | $140 → $185 | Upgrade | Equal-Weight → Overweight | Get Alert |
11/17/2021 | Buy Now | 550% | Needham | Mayank Tandon | — | Maintains | Buy | Get Alert |
09/30/2021 | Buy Now | 366.67% | Morgan Stanley | James Faucette | — | Maintains | Equal-Weight | Get Alert |
09/29/2021 | Buy Now | 316.67% | Deutsche Bank | Bryan Keane | — | Maintains | Hold | Get Alert |
08/27/2021 | Buy Now | 450% | Needham | Mayank Tandon | — | Maintains | Buy | Get Alert |
07/14/2021 | Buy Now | 356.67% | Citigroup | Ashwin Shirvaikar | — | Maintains | Buy | Get Alert |
The latest price target for Endava (NYSE:DAVA) was reported by Guggenheim on May 24, 2024. The analyst firm set a price target for $55.00 expecting DAVA to rise to within 12 months (a possible 83.33% upside). 32 analyst firms have reported ratings in the last year.
The latest analyst rating for Endava (NYSE:DAVA) was provided by Guggenheim, and Endava maintained their buy rating.
The last upgrade for Endava PLC happened on May 1, 2024 when HSBC raised their price target to $45. HSBC previously had a hold for Endava PLC.
The last downgrade for Endava PLC happened on March 1, 2024 when Citigroup changed their price target from $90 to $40 for Endava PLC.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Endava, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Endava was filed on May 24, 2024 so you should expect the next rating to be made available sometime around May 24, 2025.
While ratings are subjective and will change, the latest Endava (DAVA) rating was a maintained with a price target of $60.00 to $55.00. The current price Endava (DAVA) is trading at is $30.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.